Related Experiment Video
Updated: May 3, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Aortic valve stenosis and lipid-lowering therapy: the state of the art
I Bonadei1, E Vizzardi, A D'aloia
1Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine,, University of Study of Brescia, Brescia, Italy - enrico.vizzardi@tin.it.
Insights
Statins show promise for treating aortic valve stenosis (AS), a common heart valve disease. Research suggests AS shares mechanisms with atherosclerosis, making statins a potential therapeutic option.
Area of Science:
- Cardiology
- Biomedical research
- Pharmacology
Background:
- Aortic valve stenosis (AS) is the most prevalent native valve disease.
- Calcification of the trileaflet aortic valve is the primary cause of AS in Western countries.
- Emerging evidence links valve calcification mechanisms to those of atherosclerosis.
Purpose of the Study:
- To review and analyze current research on aortic valve stenosis.
- To explore the potential of anti-atherosclerosis medications in treating AS.
- To discuss the rationale for using statins in patients with AS.
Main Methods:
- Systematic review of contemporary studies.
- Analysis of evidence linking atherosclerosis and aortic valve calcification.
- Evaluation of the pleiotropic effects of statins.
Main Results:
- Atherosclerosis and aortic valve calcification share common underlying mechanisms.
- Statins possess pleiotropic effects beneficial for cardiovascular health.
- Contemporary studies suggest potential efficacy of statins in AS therapy.
Conclusions:
- The shared pathophysiology between AS and atherosclerosis supports investigating anti-atherosclerosis drugs.
- Statins are a promising therapeutic candidate for aortic valve stenosis due to their multifaceted benefits.
- Further research is warranted to confirm the efficacy of statins in managing AS populations.
Abstract:
Aortic valve stenosis is the most common native valve disease and its most common cause in the United States and Europe is the calcification of a normal trileaflet. Recently, there is increasing evidence indicating that valve calcification has common underlying mechanisms with atherosclerosis. This connection raises interest in the potential efficacy of antiatherosclerosis medications in calcific valve stenosis (AS) therapy. Among them statins, are one of the most promising candidates, because of their pleiotropic effects. The aim of this review is to summarize and analyze the findings of contemporary studies and to discuss the rationale for statin usage in AS populations.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Aortic Regurgitation III: Medical Management
Atherosclerosis I: Introduction
Mitral Stenosis III: Medical Management
Atherosclerosis IV: Nursing Management

